Cytokinetics Grants 60,465 Stock Options, 40,084 RSUs to 29 New Employees

• Cytokinetics granted stock options covering 60,465 shares and 40,084 restricted stock units on October 15, 2026.
• The awards cover 29 employees whose employment began in September and October 2026.
• Restricted stock units vest over three years: 40% on each of the first two grant anniversaries, then 20% on the third.
• Stock options vest over four years, with 25% vesting after one year; the remainder vests monthly over the next 36 months.
• The options have a 10-year term. Vesting of both award types requires continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610191600PRIMZONEFULLFEED9848689) on October 19, 2026, and is solely responsible for the information contained therein.